Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
William Radford Lovett II, a significant ten percent shareholder in Dream Finders Homes, Inc. (NASDAQ:DFH), executed a series of stock disposals totaling over $2 million in mid-June 2026. The transactions, processed through the W. Radford Lovett II GST Exempt Trust, involved the sale of 130,601 Class A common shares at prices exceeding the current …
NovaBridge Biosciences (NASDAQ:NBP) Chief Medical Officer Dennis Phillip Andrew has executed a sale of company securities, according to a newly filed Form 4 with the Securities and Exchange Commission. The transaction occurred against a backdrop of significant corporate developments, including the acquisition of Fast Track Designation for its drug …
Mark Elliott Boulding, Executive Vice President and Chief Legal Officer at PTC Therapeutics, Inc. (NASDAQ:PTCT), executed a series of stock transactions on June 17, 2026, as detailed in a recent Securities and Exchange Commission (SEC) filing. Mr. Boulding sold 10,462 shares of the company's common stock, realizing approximately $822,867. The sales…
Christine Marie Utter, Senior Vice President and Chief Accounting Officer at PTC Therapeutics, Inc. (NASDAQ:PTCT), executed a significant sale of company stock on June 17, 2026, totaling approximately $1.49 million. The transaction involved the sale of 19,686 shares at $75.56 per share, which were acquired earlier that same day through the exercise…
Paulson & Co. Inc., which holds a 10% stake in Acadian Asset Management Inc. (AAMI), executed a substantial divestment of its common stock in mid-June 2026. The sale occurred at a time when Acadian Asset Management had just reported first-quarter financial results that materially exceeded market consensus, highlighting a divergence between the inve…
Voip-pal.com Inc. (OTCMKTS:VPLM) Chief Financial Officer Kuang Jin executed a series of stock sales totaling $7,600, according to a recent Form 4 filing with the Securities and Exchange Commission. The transactions, completed over three consecutive days in mid-June, underscore the ongoing liquidity dynamics and valuation perceptions surrounding the…
Enliven Therapeutics, Inc. (NASDAQ: ELVN) reported a significant insider transaction as Chief Financial Officer Benjamin Hohl executed the sale of 6,018 shares of the company's common stock on June 17, 2026. The transaction, valued at $263,577, was conducted through a Rule 10b5-1 trading plan adopted earlier in the year. This sale follows a period …
Helen Louise Collins, Chief Medical Officer at Enliven Therapeutics, Inc. (NASDAQ: ELVN), executed a series of stock transactions on June 17, 2026. The activities included the sale of 4,900 shares and the exercise of stock options. These trades occurred within the framework of a pre-arranged Rule 10b5-1 trading plan. The corporate developments also…
Robert Parahus, President and COO of Toll Brothers, Inc. (NYSE:TOL), executed a significant equity transaction on June 18, 2026, by transferring 7,500 shares of common stock into an exchange fund. The transaction was valued at approximately $1,122,450, with the company's stock priced at $149.66 per share for calculation purposes. This move follows …
Diana Frost, Kraft Heinz's Global Chief Growth Officer, executed a sale of 18,502 shares on June 18, 2026, totaling approximately $426,532. The sale occurs as the company navigates a significant global operational restructuring and faces financial headwinds, including a recent downgrade from Bernstein SocGen Group. Despite the stock trading near it…
Thomas R. Cellitti, a director at Core Molding Technologies Inc. (NASDAQ:CMT), executed a sale of the company's common stock totaling $60,172 over two days in mid-June 2026. The transaction follows a period of strong stock performance and occurs alongside significant corporate developments, including a planned CEO transition and recent quarterly fi…
Arrow Financial Corp (NASDAQ:AROW) director Mark Behan executed a mixed set of transactions on June 17, 2026, selling 4,110 shares valued at $158,604 while simultaneously acquiring 203 shares through a quarterly director's retainer. The transaction occurs as the bank's stock trades near its 52-week peak of $40.29, following a substantial 60% gain o…
NextTrip, Inc. (NASDAQ:NTRP) director David T. Jiang recently executed a transaction to acquire 18,200 shares of the company's common stock at $2.75 per share, totaling $50,050. The purchase also included 18,200 warrants with an exercise price of $2.75, exercisable until June 18, 2029. Following the transaction, Jiang holds 1,582,157 shares and 92,…
Kathleen Goin, Chief Operating Officer of Palvella Therapeutics, Inc. (NASDAQ: PVLA), executed a sale of 4,302 shares on June 17, 2026, realizing approximately $476,372 in proceeds. The transaction, conducted under a pre-established Rule 10b5-1 trading plan, followed the exercise of fully vested stock options valued at $34,883. Following the sale, …
Scott R. Lovett, President of Go to Market at Fastly, Inc. (NASDAQ:FSLY), executed a sale of 41,716 shares of the company's Class A Common Stock on June 17, 2026, generating proceeds of $741,293. The transaction was conducted under a Rule 10b5-1 trading plan adopted on February 28, 2025. Following the sale, Lovett retains direct ownership of 1,392,…
Stacey Friedman, general counsel at JPMorgan Chase & Co., executed a sale of 5,467 shares on June 22, 2026, for approximately $1.8 million. The transaction took place while JPMorgan shares were trading close to their 52-week peak of $338.09, with the stock closing at $331.76 on the day of the sale. Following the transaction, Friedman retains direct…
Global GP LLC, the general partner of Global Partners LP (NYSE:GLP), executed a series of common unit purchases totaling $430,450 in mid-June 2026. The transactions, comprising 10,000 units, were conducted to satisfy obligations under the company's Long-Term Incentive Plan. This activity occurs against a backdrop of mixed financial results for the …
John Baylouny, President and Chief Executive Officer of Leonardo DRS, Inc. (NASDAQ: DRS), executed a sale of 36,471 shares of common stock on June 18, 2026. The transaction, valued at $1,665,630, was conducted at prices between $45.00 and $46.94 per share. This sale occurs against a backdrop of a 33% surge in Leonardo DRS shares over the preceding …
W. Nicholas Howley, a director at TransDigm Group INC (NASDAQ:TDG), executed a series of substantial transactions on June 18, 2026, involving both the sale and acquisition of company stock. The director sold 9,381 shares for approximately $13.37 million while simultaneously exercising stock options to acquire 10,132 shares. These transactions occur…
W. Nicholas Howley, a director at TransDigm Group Inc. (NASDAQ: TDG), executed a series of transactions involving the company's common stock on June 18, 2026. The director sold 10,132 shares for approximately $13.37 million, while simultaneously acquiring an equal number of shares through stock option exercises. This activity occurs against the bac…
Scott A. Lang, President and Chief Executive Officer of Anterix Inc., executed a transaction involving the disposal of company common stock on June 18, 2026. The transaction resulted in a total sale value of $13,642. This activity occurs against a backdrop of recent stock performance, where shares have experienced a 10% decline over the preceding w…
Guidewire Software CEO Michael George Rosenbaum sold 1,200 shares on June 22, 2026, at $105.67 per share, totaling $126,804. The sale was executed automatically under a 10b5-1 trading plan adopted on October 14, 2025. Following the transaction, Rosenbaum directly holds 198,576 shares. The sale occurs as Guidewire stock trades near its 52-week low o…
Jeffrey Elliott Cooper, Chief Financial Officer of Guidewire Software, Inc., has executed a transaction to dispose of 1,348 shares of the company's common stock on June 22, 2026. The sale, which netted $142,443, was facilitated at a per-share price of $105.67. This transaction was automatically processed under a pre-arranged 10b5-1 trading plan tha…
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) director Susan B. McGee has completely exited her position in the company, selling her remaining common shares across two transactions in mid-June 2026. The sales occurred at prices of $4.24 and $4.25 per share, totaling $884,442. This divestment comes as HIVE Digital navigates a period of significant op…
Martine Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), executed a series of stock transactions on June 18, 2026, under a pre-arranged 10b5-1 trading plan established in November 2025. The transactions involved the sale of 9,500 shares valued at approximately $5.13 million, following the exercise of sto…
